TBPH insider buying and SEC filings, explained
Theravance Biopharma, Inc. · CIK 1583107
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$5.9M
Planned sales (10b5-1)
$2.9M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 15, 2026 | Planned (10b5-1) | Rhonda Farnum (SVP, Comm & Medical Affairs) sold 13,314 shares at about $17.03 ($227K), marked as a 10b5-1 plan trade. Holdings down 6% to 213,476 shares. | SEC filing Filed Sep 17, 2026 |
| Jul 6–7, 2026 | Sale | Eli Samaha (10% owner) sold 6,964 shares indirectly between Jul 6 and Jul 7 at about $17.14 ($119K). Indirect holdings down <1% to 9,167,489 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 8, 2026 |
| Jun 29–Jul 1, 2026 | Sale | Eli Samaha (10% owner) sold 336,697 shares indirectly between Jun 29 and Jul 1 at about $17.20 ($5.8M). Indirect holdings down 4% to 9,174,453 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 1, 2026 |
| Jun 15, 2026 | Planned (10b5-1) | Rhonda Farnum (SVP, Comm & Medical Affairs) sold 13,314 shares at about $16.39 ($218K), marked as a 10b5-1 plan trade. Holdings down 5% to 232,457 shares. | SEC filing Filed Jun 17, 2026 |
| Mar 16, 2026 | Planned (10b5-1) | Rhonda Farnum (SVP, Comm & Medical Affairs) sold 31,067 shares at about $13.96 ($434K), marked as a 10b5-1 plan trade. Holdings down 12% to 232,699 shares. | SEC filing Filed Mar 18, 2026 |
| Dec 3, 2025 | Planned (10b5-1) | Rhonda Farnum (SVP, Comm & Medical Affairs) sold 31,067 shares at about $18.75 ($583K), marked as a 10b5-1 plan trade. Holdings down 10% to 277,695 shares. | SEC filing Filed Dec 5, 2025 |
| Nov 26, 2025 | Planned (10b5-1) | Eran Broshy (Director) sold 29,501 shares at $20.00 ($590K), marked as a 10b5-1 plan trade. Holdings down 40% to 44,703 shares. | SEC filing Filed Dec 1, 2025 |
| Nov 11, 2025 | Planned (10b5-1) Amended filing | Eran Broshy (Director) sold 45,000 shares at about $17.98 ($809K), marked as a 10b5-1 plan trade. Holdings down 43% to 60,204 shares. This amends a filing from Nov 13, 2025. | SEC filing Filed Nov 14, 2025 |
43 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow TBPH in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.